News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,727 Results
Type
Article (8036)
Company Profile (140)
Press Release (476646)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166763)
Career Advice (305)
Deals (25742)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238247)
Policy (17922)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (105)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (264)
Approvals (10378)
Artificial intelligence (321)
ASCO (159)
Autoimmune disease (206)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (510)
Cancer (3655)
Cardiovascular disease (218)
Career advice (245)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47878)
Collaboration (1247)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (753)
Cystic fibrosis (85)
Data (5665)
Denatured (4)
Depression (102)
Dermatology (62)
Diabetes (344)
Diagnostics (4187)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73717)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87626)
Executive appointments (701)
FDA (12399)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (125)
Generative AI (9)
Gene therapy (319)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9318)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (251)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8658)
Medtech (8803)
Mergers & acquisitions (14387)
Metabolic disorders (709)
mRNA (56)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (221)
Neuropsychiatric disorders (39)
Neuroscience (1827)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (225)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (197)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (509)
Peanut (31)
People (41244)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15469)
Phase 2 (21382)
Phase 3 (14404)
Pipeline (7349)
Policy (18)
Postmarket research (1570)
Preclinical (6539)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (575)
Real estate (3019)
Recruiting (6)
Regulatory (14833)
Reports (21)
Research institute (582)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (324)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (52)
Last 7 days (212)
Last 30 days (1597)
Last 365 days (19050)
2026 (12359)
2025 (19251)
2024 (22989)
2023 (26541)
2022 (34587)
2021 (37167)
2020 (33468)
2019 (23257)
2018 (17468)
2017 (18765)
2016 (17921)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20222)
2011 (20440)
2010 (20333)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17898)
Australia (2098)
California (11992)
Canada (3149)
China (524)
Colorado (485)
Connecticut (409)
Delaware (208)
Europe (24630)
Florida (1790)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (700)
India (51)
Indiana (315)
Iowa (15)
Japan (405)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1203)
Massachusetts (7862)
Michigan (308)
Minnesota (560)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2621)
New Mexico (12)
New York (2823)
North Carolina (1280)
North Dakota (4)
Northern California (6006)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2255)
Puerto Rico (20)
Rhode Island (35)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4984)
Tennessee (120)
Texas (1943)
United States (38918)
Utah (361)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (929)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,727 Results for "nabsys inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies
August 2, 2026
·
4 min read
Press Releases
Nabsys Appoints Genome Mapping Pioneer Alka Chaubey, Ph.D., as Chief Medical and Genomics Officer
July 6, 2026
·
5 min read
Press Releases
Nabsys Announces Advancements in Detection of Repeat Contraction and Expansion Disorders Via Electronic Genome Mapping in Collaboration with Leading European Institutions
June 15, 2026
·
5 min read
Press Releases
Nabsys Announces New OhmX Platform Installations Under Hitachi High-Tech America’s RAMP UP Program with Leading Cytogeneticist to Advance Applications in Hematologic Malignancies
May 17, 2026
·
7 min read
Press Releases
Nabsys Announces Key Leadership Appointments
October 29, 2024
·
3 min read
Hitachi High-Tech America, Inc. and Nabsys to collaborate through a “Rapid Application to Market Penetration User Partnership” Program to advance the OhmX Electronic Genome Mapping Platform
The collaboration aims to continue to gain commercial traction after Nabsys announced the OhmX platform in October 2023.
February 5, 2024
·
3 min read
Press Releases
Hitachi High-Tech Acquires Majority Interest in Nabsys
August 2, 2024
·
4 min read
Business
Justin Bingham Joins Nabsys as Chief Commercial Officer
Nabsys, the pioneer in electronic whole-genome mapping, announced that Justin Bingham has joined the company as its Chief Commercial Officer.
October 19, 2022
·
2 min read
Business
Kevin DeGeeter Joins Nabsys as Chief Financial Officer
Nabsys, the pioneer in electronic whole-genome mapping, announced the appointment of Kevin DeGeeter as Chief Financial Officer.
July 18, 2022
·
3 min read
Genetown
Nabsys Raises $25 Million Equity Round
Nabsys, the pioneer in electronic whole-genome mapping, announced that it has closed on $25 million in funding with strategic partner Hitachi High-Tech Corporation.
April 13, 2022
·
2 min read
1 of 48,473
Next
